Stay updated on TATE-PD1 Combo in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.

Latest updates to the TATE-PD1 Combo in Liver Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedGastric cancer added as a condition for the study. Resources section now includes a link to the Genetic and Rare Diseases Information Center.SummaryDifference0.2%

- Check34 days agoChange DetectedRevision: v3.4.2 is displayed. The prior government-funding operating-status notice has been removed; core study details remain unchanged.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide funding/status notice was added and the site version updated to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check49 days agoChange DetectedThe page updates add a Show glossary option, adjust labeling for QC status, and update footer/version text related to No FEAR Act and revisions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check56 days agoChange DetectedThe revision label on the page was updated from v3.3.3 to v3.3.4. No substantive content or functionality changes were observed.SummaryDifference0.1%

Stay in the know with updates to TATE-PD1 Combo in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.